ZEB1 and melanoma: Furthermore, our findings that KPC1 acts upstream to control ZEB1 stability align with and provide a novel regulatory mechanism for previous studies highlighting ZEB1 as a central mediator of invasive and therapy-resistant melanoma states [18].